a 2019

Development of an innovative nanostructured dermal matrix in combination with a hyperstable form of growth factor for fibroblasts (FGF2): Ex ovo and in vivo study

HOLOUBEK, Jakub; Břetislav LIPOVÝ; Martin KNOZ; Lucy VOJTOVÁ; Johana BABRNÁKOVÁ et. al.

Basic information

Original name

Development of an innovative nanostructured dermal matrix in combination with a hyperstable form of growth factor for fibroblasts (FGF2): Ex ovo and in vivo study

Authors

HOLOUBEK, Jakub; Břetislav LIPOVÝ; Martin KNOZ; Lucy VOJTOVÁ; Johana BABRNÁKOVÁ; Veronika PAVLINAKOVA; Lucie VISTEJNOVA; Veronika ŠTĚPÁNKOVÁ; Eva FILOVA; Zdeněk PAVLOVSKÝ; Martin FALDYNA; Eduard GÖPFERT; Jiří DAMBORSKÝ and Vanessa HEARNDEN

Edition

10th Congress of World Society for Reconstructive Microsurgery, Bologna, Italy, 2019

Other information

Type of outcome

Conference abstract

Confidentiality degree

is not subject to a state or trade secret
Changed: 5/7/2019 18:57, MUDr. Jakub Holoubek, Ph.D.